Quantcast

Latest Transplantation medicine Stories

2014-02-24 12:26:25

GRAPEVINE, Texas, Feb. 24, 2014 /PRNewswire-USNewswire/ -- Just 10 years ago, older patients were typically considered ineligible to receive a blood or bone marrow transplantation (BMT) to treat their blood cancer, but today, patients age 65 and older not only qualify for BMT therapy but are the fastest growing group of recipients. This was reported at the American Society for Blood and Marrow Transplantation (ASBMT) annual meeting as it celebrates its 20(th) anniversary and reflects...

2014-02-19 12:28:05

LUND, Sweden, Feb. 19, 2014 /PRNewswire/ -- BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced today the launch of a new registry to collect long term data of CERAMENT(TM)|G, the first injectable antibiotic eluting, osteoconductive, ceramic bone substitute indicated to promote and protect bone healing being jeopardized by infection. The registry is part of the company's...

2014-02-18 16:26:44

CENTENNIAL, Colo., Feb. 18, 2014 /PRNewswire-USNewswire/ -- Peter Stevens, the Vice President of Research & Development and Marketing at AlloSource (allosource.org), one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures, and the world's largest processor of cellular bone allografts, has been named to the Advisory Board for the University of Denver's Professional Sciences Master's Program in Biomedical Sciences....

2014-02-18 09:01:07

A new study describes the complexity of the new T cell repertoire following immune-depleting therapy to treat multiple sclerosis, improving our understanding of immune tolerance and clinical outcomes. In the Immune Tolerance Network's (ITN) HALT-MS study, 24 patients with relapsing, remitting multiple sclerosis received high-dose immunosuppression followed by a transplant of their own stem cells, called an autologous stem cell transplant, to potentially reprogram the immune system so that...

2014-02-18 08:32:06

NEWPORT BEACH, Calif., Feb. 18, 2014 /PRNewswire/ -- BioStructures, LLC, a privately held orthobiologics company, today announced that the United States Food and Drug Administration has granted 510(k) clearance for Bioactive Bone Graft Putty (Signafuse(TM)). Signafuse(TM) is indicated for the posterolateral spine, extremities and pelvis as well as a bone graft extender in the posterolateral spine. Signafuse(TM) represents a new class of synthetic biomaterials designed for...

2014-02-14 12:24:24

DUBLIN, February 14, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/n7sxmf/autologous_tissue) has announced the addition of the "Autologous Tissue Repair to 2018. Products, Indications, Markets and Forecasts" [http://www.researchandmarkets.com/research/n7sxmf/autologous_tissue ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The ability to isolate, purify and re-inject...

2014-02-11 04:20:16

ALBANY, New York, February 11, 2014 /PRNewswire/ -- MarketResearchReports.Biz includes new market research report "Range Extenders for ElectricVehiclesLand, Water & Air 2013-2023" to its large collection of research reports. http://www.marketresearchreports.biz/analysis-details/range-extenders-for-electric-vehicles-land-water-and-air-2013-2023 We are in the decade of the hybrid electric vehicle despite the fact that most off road and underwater vehicles are...

2014-02-06 08:29:07

ALBANY, New York, February 6, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Organ Preservation Solutions Market (By Solutions-Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and Others, and By Preservation Techniques- Hypothermic Perfusion Preservation, Static Cold Storage and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,"in...

2014-02-03 16:25:36

Flexible, cancellous bone allografts are used in spine surgery, either alone or as a bone graft extender to stimulate natural bone formation processes MINNEAPOLIS, Feb. 3, 2014 /PRNewswire/ -- Zimmer Spine, Inc., a global leader in spine innovation, today announced the U.S. market launch of Puros Demineralized Bone Matrix (DBM) Block and Strip -- bone graft substitutes used to stimulate natural bone formation processes in spine surgical procedures. Used alone or as a bone graft...

2014-01-31 23:27:30

GIA announces the release of a comprehensive global report on Bone Grafts markets. Global market for Bone Graft Substitutes is projected to reach US$2.9 billion by 2020, driven primarily by aging global population, increasing number of orthopedic surgeries, advances in bone graft materials, and development of innovative products. San Jose, California (PRWEB) January 31, 2014 Follow us on LinkedIn - Bone is the second largest transplanted tissue after blood. Bone grafting are procedures...


Latest Transplantation medicine Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »
Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.